Compare AltheaDx vs AviaraDX
Customers evaluate the quality of AltheaDx's products using the following success metrics.
Overview
AltheaDx is 15 yrs old and is based in United States.
AltheaDx is a commercial stage personalized medicine company which focuses on enabling physicians, managed care organizations, pharmaceutical companies and other healthcare entities to make personalized therapeutic decisions for patients. AltheaDx's IDgenetix pharmacogenetics product testing portfolio addresses some of the most prevalent clinical conditions in the United States, including cardiovascular disease, neuropsychiatric disorders and pain. AltheaDx was founded in 2009 and is headquartered in San Diego, California. On April 4th, 2022, AltheaDx was acquired by Castle Biosciences. The terms of the transaction were not disclosed.
AviaraDX is 28 yrs old and is based in United States.
AviaraDX develops and introduces new diagnostic technologies for molecular cancer profiling.
Demo Video
Leadership
François Ferré (Founder)
Antonius Schuh (Chief Executive Officer)
Investors
Castle Biosciences, ALMA Life Sciences
bioMerieux, ONSET Ventures
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because AltheaDx has not claimed their profile.
Work for AltheaDx? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for AltheaDx?
Claim your profile now.
Information not available because AviaraDX has not claimed their profile.
Work for AviaraDX? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for AviaraDX?
Claim your profile now.
Expert Collections
Digital Health
10,563 items
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.